Evidence mapPaperPMID 41904530Full record

ReviewBiological research2026

Alternatives for fetal bovine serum (FBS) and sustainability of milk derivatives in cell culture.

Olga Maria Pittino, Maria Sofia Semprini, Lac2Lab, Francesca Ruzzi, Stefania Angelicola, Chiara Cappello, Laura Scalambra, Mariateresa Frascino, Patrick L S Michel, Patrizia Nanni and 2 more

Abstract readReview
In one paragraph

Review in Biological research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Olga Maria Pittino *Laboratory of Immunology and Biology of Metastasis, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
Maria Sofia Semprini *Laboratory of Immunology and Biology of Metastasis, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
Lac2Lab
Francesca RuzziLaboratory of Immunology and Biology of Metastasis, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
Stefania AngelicolaMedical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Chiara CappelloLaboratory of Immunology and Biology of Metastasis, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
Laura ScalambraCenter of Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italia.
Mariateresa FrascinoDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Patrick L S MichelDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Patrizia NanniLaboratory of Immunology and Biology of Metastasis, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
Pier-Luigi LolliniLaboratory of Immunology and Biology of Metastasis, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.
Arianna PalladiniDepartment of Molecular Medicine, University of Pavia, Pavia, Italy. arianna.palladini@unipv.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fetal bovine serum (FBS) is frequently used as a media supplement in cell cultures, as it contains many nutrients, growth factors, and hormones crucial to sustaining cell growth in vitro. However, over the years, concerns about its use have been highlighted. The unknown composition, batch-to-batch variability, and increasing demand and prices have raised scientific and economic issues. In addition, the collection procedure has raised ethical concerns. These issues have prompted researchers worldwide to explore more sustainable and reproducible alternatives performing like FBS. In this review, we examine several potential FBS substitutes, derived from other animal sources or chemically defined sera. Among the considered alternatives, milk emerges as a relevant and suitable option, helping to steer the biotechnological progress towards a more ethical and sustainable approach. Food waste is a globally widespread problem, and milk is no exception. Its use as an alternative supplement for cell cultures could contribute to a reduction in food waste and in the FBS usage, limiting the drawbacks associated with it. Furthermore, milk is often referred to as the “perfect food” as it is rich in nutrients fundamental to sustaining growth, resembling FBS characteristics. Bovine milk derivatives have proven effective in reducing and, in some cases, fully replacing FBS, therefore representing an interesting and feasible option as supplements for culture media. Considering that, requalified milk could help address both social and economic needs and, through circular economy strategies, reduce costs for the biotechnological industry and enhance environmental sustainability.

Indexed as

Cell Culture TechniquesCulture MediaMilkSerumAnimalsCattleCulture MediaCell culture mediaFBSMilk-derived componentsSerum substitutesSustainable alternatives

Identifiers

PMID41904530
PMCPMC13151094

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.